OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients
Clinical trial NCT03698227 · TERMINATED
Trial details
- NCT number
- NCT03698227
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-06-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.